Home › Degenerasyon ng Macula › New Jersey
Pag-aaral pangklinika para sa Degenerasyon ng Macula sa New Jersey
7 pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Opisyal na teksto ng pag-aaral (English)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Mid Atlantic Retina, Cherry Hill
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07440225A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Mid Atlantic Retina - Cherry Hill, Cherry Hill
- New Jersey Retina, Teaneck
- New Jersey Retina, Toms River
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06541704A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Envision Ocular, LLC, Bloomfield
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 171, Teaneck
Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07630649Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Envision Ocular, LLC, Bloomfield
Nagre-recruitPhase 3
Edad 50 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07064759Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection
- Contact Lens & Vision, Woodbridge
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT07446582Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Atlantic Eye Physicians, Eatontown
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Dis 3, 2024 · NCT05438732Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.